IXHL logo

IXHL

Profile

Full Name

Incannex Healthcare Inc.

Ticker Symbol

IXHL

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Australia

IPO

March 2, 2022

Indexes

Not included

Website

http://www.incannex.com

Employees

9

Key Details

Price

$0.62(+1.64%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$12.00K

Annual EPS

-$1.15(+65.36% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.62
IXHL price is $0.62

30-Day Relative Volume

0.15
IXHL 30-day relative volume is 0.15

Price Performance

Price Most recent change

+1.64%
IXHL price was up +1.64% on Apr 16, 2025

Price YTD change

-70.75%
IXHL price is down -70.75% since January 1st

Price 1-year change

-74.49%
IXHL price is down -74.49% year-on-year

Price 3-year change

-92.15%
IXHL price is down -92.15% over the past 3 years

Price Range

Price All-time high

$96.07
IXHL price is currently -99.35% below its historical high of $96.07

Price 3-year low

$0.47
IXHL price is currently +31.63% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$17.08M
IXHL market capitalization is $17.08 million

Market cap 3-year change

-82.14%
IXHL market capitalization is down -82.14% over the past 3 years

Market cap All-time high

$429.03M
IXHL market capitalization is currently -96.02% below its historical high of $429.03 million

Market cap sector rank

25.82%
IXHL market capitalization is higher than 25.82% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+73.54%
IXHL shares outstanding is up +73.54% year-on-year

Shares Outstanding 3-Year Change

+127.59%
IXHL shares outstanding is up +127.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.34
IXHL beta is -0.34

200-day SMA

$1.77
IXHL price is currently -65.03% below its 200-day simple moving average

50-day SMA

$1.09
IXHL price is currently -42.89% below its 50-day simple moving average

RSI

40.54
IXHL 14-day relative strength index is 40.54

Volume

0.15
IXHL 30-day relative volume is 0.15

ATR

$0.12
IXHL average true range is $0.12

10-day Historical Volatility

410.51%
IXHL 10-day historical volatility is 410.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$12.00K
IXHL annual revenue is $12.00 thousand

Revenue Analysts estimate

$472.00K
IXHL annual revenue is currently -97.46% lower than the consensus analysts' forecast

Revenue 1-year change

-
IXHL annual revenue 1-year change is unknown

Revenue Sector rank

2.35%
IXHL annual revenue is higher than 2.35% of companies in Healthcare sector

EPS

EPS

-$1.15
IXHL annual earnings per share is -$1.15

EPS Analysts estimate

-
IXHL annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+65.36%
IXHL annual earnings per share is up +65.36% year-on-year

EPS Sector rank

53.22%
IXHL annual earnings per share is higher than 53.22% of companies in Healthcare sector

Profit

Gross profit

-
IXHL annual gross profit value is unknown

Gross margin

-
IXHL annual gross profit margin value is unknown

Operating profit

-$18.61M
IXHL annual operating income is -$18.61 million

Operating margin

-155.06K%
IXHL annual operating profit margin is -155.06 thousand%

Net income

-$18.46M
IXHL annual net profit is -$18.46 million

Net margin

-153.82K%
IXHL annual net profit margin is -153.82 thousand%

Expenses

Total expenses

$18.62M
IXHL annual total expenses is $18.62 million

Operating expenses

$18.62M
IXHL annual total operating expenses is $18.62 million

Cost of goods sold

-
IXHL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.07M
IXHL annual SGA is $17.07 million

Depreciation and amortization

$103.00K
IXHL annual depreciation & amortization is $103.00 thousand

Interest expense

-
IXHL annual interest expense value is unknown

Income tax

$30.00K
IXHL annual income tax is $30.00 thousand

EBIT & EBITDA

EBIT

-$18.61M
IXHL annual earnings before interest & taxes is -$18.61 million

EBITDA

-$18.50M
IXHL annual EBITDA is -$18.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$17.05M
IXHL annual total assets is $17.05 million

Non current assets

$845.00K
IXHL annual long term assets is $845.00 thousand

Current assets

$16.20M
IXHL annual total current assets is $16.20 million

Cash and cash equivalents

$5.86M
IXHL annual cash & cash equivalents is $5.86 million

Accounts receivable

-
IXHL annual accounts receivable value is unknown

Inventory

-
IXHL annual inventory value is unknown

Liabilities

Total liabilities

$5.83M
IXHL annual total liabilities is $5.83 million

Long term liabilities

$210.00K
IXHL annual total long term liabilities is $210.00 thousand

Current liabilities

$5.62M
IXHL annual total current liabilities is $5.62 million

Accounts payable

$527.00K
IXHL annual accounts payable is $527.00 thousand

Debt

Total debt

$373.00K
IXHL annual total debt is $373.00 thousand

Total debt 1-year change

-28.41%
IXHL annual total debt is down -28.41% year-on-year

Long term debt

$210.00K
IXHL annual long term debt is $210.00 thousand

Short term debt

$163.00K
IXHL annual short term debt is $163.00 thousand

Equity & Capital

Shareholders equity

$11.22M
IXHL annual stockholders equity is $11.22 million

Book value

$11.22M
IXHL annual book value is $11.22 million

Retained earnings

-$110.67M
IXHL annual retained earnings is -$110.67 million

Working capital

$10.58M
IXHL annual working capital is $10.58 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$15.85M
IXHL annual cash flow from operations is -$15.85 million

Cash from operations 1-year change

-47.41%
IXHL annual cash flow from operations is down -47.41% year-on-year

Cash from investing

-$277.00K
IXHL annual cash flow from investing activities is -$277.00 thousand

Cash from investing 1-year change

+12.34%
IXHL annual cash flow from investing activities is up +12.34% year-on-year

Cash from financing

$0.00
IXHL annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
IXHL annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

$277.00K
IXHL annual capital expenditures is $277.00 thousand

CAPEX 1-year change

-12.34%
IXHL annual capital expenditures is down -12.34% year-on-year

Free Cash Flow

Free cash flow

-$16.12M
IXHL annual free cash flow is -$16.12 million

Free cash flow 1-year change

-45.7%
IXHL annual free cash flow is down -45.7% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
IXHL annual gross profit margin value is unknown

Operating margin

-155.06K%
IXHL annual operating profit margin is -155.06 thousand%

Net margin

-153.82K%
IXHL annual net profit margin is -153.82 thousand%

ROA & ROE

ROA

-90.42%
IXHL annual return on assets is -90.42%

ROE

-115.22%
IXHL annual return on equity is -115.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IXHL price to earnings ratio value is unknown

PE ratio Sector rank

-
IXHL price to earnings ratio is unknown

PB Ratio

PB ratio

17.70
IXHL price to book ratio is 17.70

PB ratio Sector rank

96.54%
IXHL price to book ratio is higher than 96.54% of companies in Healthcare sector

PS Ratio

PS ratio

174.28
IXHL price to sales ratio is 174.28

PS ratio Sector rank

96.41%
IXHL price to sales ratio is higher than 96.41% of companies in Healthcare sector

Enterprise value

Enterprise value

$19.08M
IXHL enterprise value is $19.08 million

Enterprise value Sector rank

31.27%
IXHL enterprise value is higher than 31.27% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.81
IXHL EV/EBITDA is -0.81

EV/EBITDA Sector rank

45.78%
IXHL EV/EBITDA is higher than 45.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.88
IXHL annual current ratio is 2.88

Quick ratio

-
IXHL annual quick ratio value is unknown

Leverage

Debt to equity

0.00
IXHL annual debt to equity ratio is 0.00

Interest coverage ratio

-
IXHL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
IXHL piotroski f-score value is unknown

Altman Z-Score

-10.19
IXHL altman z-score is -10.19

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

IRIX logo
IRIDEX (IRIX)
HBIO logo
Harvard Bioscience (HBIO)
NMTC logo
NeuroOne Medical Technologies (NMTC)
AMS logo
American Shared Hospital Services (AMS)
BCTX logo
BriaCell Therapeutics (BCTX)
MIRA logo
MIRA Pharmaceuticals (MIRA)
EDSA logo
Edesa Biotech (EDSA)
LSTA logo
Lisata Therapeutics (LSTA)
VSee Health (VSEE)
  • What is the ticker symbol for Incannex Healthcare Limited?
  • Does Incannex Healthcare Limited pay dividends?
  • What sector is Incannex Healthcare Limited in?
  • What industry is Incannex Healthcare Limited in?
  • What country is Incannex Healthcare Limited based in?
  • When did Incannex Healthcare Limited go public?
  • Is Incannex Healthcare Limited in the S&P 500?
  • Is Incannex Healthcare Limited in the NASDAQ 100?
  • Is Incannex Healthcare Limited in the Dow Jones?
  • When was Incannex Healthcare Limited's last earnings report?
  • When does Incannex Healthcare Limited report earnings?
  • Should I buy Incannex Healthcare Limited stock now?

What is the ticker symbol for Incannex Healthcare Limited?

The ticker symbol for Incannex Healthcare Limited is NASDAQ:IXHL

Does Incannex Healthcare Limited pay dividends?

No, Incannex Healthcare Limited does not pay dividends

What sector is Incannex Healthcare Limited in?

Incannex Healthcare Limited is in the Healthcare sector

What industry is Incannex Healthcare Limited in?

Incannex Healthcare Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Incannex Healthcare Limited based in?

Incannex Healthcare Limited is headquartered in Australia

When did Incannex Healthcare Limited go public?

Incannex Healthcare Limited's initial public offering (IPO) was on March 2, 2022

Is Incannex Healthcare Limited in the S&P 500?

No, Incannex Healthcare Limited is not included in the S&P 500 index

Is Incannex Healthcare Limited in the NASDAQ 100?

No, Incannex Healthcare Limited is not included in the NASDAQ 100 index

Is Incannex Healthcare Limited in the Dow Jones?

No, Incannex Healthcare Limited is not included in the Dow Jones index

When was Incannex Healthcare Limited's last earnings report?

Incannex Healthcare Limited's most recent earnings report was on Feb 14, 2025

When does Incannex Healthcare Limited report earnings?

The next expected earnings date for Incannex Healthcare Limited is May 15, 2025

Should I buy Incannex Healthcare Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page